Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31true02023-04-01falsefalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.No description of principal activity0true OC428034 2023-04-01 2024-03-31 OC428034 2022-04-01 2023-03-31 OC428034 2024-03-31 OC428034 2023-03-31 OC428034 c:CurrentFinancialInstruments 2024-03-31 OC428034 c:CurrentFinancialInstruments 2023-03-31 OC428034 c:CurrentFinancialInstruments c:WithinOneYear 2024-03-31 OC428034 c:CurrentFinancialInstruments c:WithinOneYear 2023-03-31 OC428034 d:FRS102 2023-04-01 2024-03-31 OC428034 d:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 OC428034 d:FullAccounts 2023-04-01 2024-03-31 OC428034 d:LimitedLiabilityPartnershipLLP 2023-04-01 2024-03-31 OC428034 d:PartnerLLP2 2023-04-01 2024-03-31 OC428034 c:FurtherSpecificReserve3ComponentTotalEquity 2024-03-31 OC428034 c:FurtherSpecificReserve3ComponentTotalEquity 2023-03-31 OC428034 e:PoundSterling 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure

Registered number: OC428034









NORFOLK HAEMATOLOGY PARTNERSHIP LLP







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2024

 
NORFOLK HAEMATOLOGY PARTNERSHIP LLP
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE MEMBERS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF NORFOLK HAEMATOLOGY PARTNERSHIP LLP
FOR THE YEAR ENDED 31 MARCH 2024

In order to assist you to fulfil your duties under the Companies Act 2006 (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008), we have prepared for your approval the financial statements of Norfolk Haematology Partnership LLP for the year ended 31 March 2024 which comprise  the Balance sheet and the related notes from the LLP's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com/regulation.

This report is made solely to the members in accordance with the terms of our engagement letter dated 22 September 2022Our work has been undertaken solely to prepare for your approval the financial statements of Norfolk Haematology Partnership LLP and state those matters that we have agreed to state to the Norfolk Haematology Partnership LLP's members in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Norfolk Haematology Partnership LLP and its members for our work or for this report. 

It is your duty to ensure that Norfolk Haematology Partnership LLP has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and result of Norfolk Haematology Partnership LLP. You consider that Norfolk Haematology Partnership LLP is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Norfolk Haematology Partnership LLP. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  





MA Partners LLP
 
Chartered Accountants
  
7 The Close
Norwich
Norfolk
NR1 4DJ
25 October 2024
Page 1

 
NORFOLK HAEMATOLOGY PARTNERSHIP LLP
REGISTERED NUMBER: OC428034

BALANCE SHEET
AS AT 31 MARCH 2024

2024
2023
Note
£
£

  

Current assets
  

Cash at bank and in hand
  
3,625
13,557

  
3,625
13,557

Creditors: Amounts Falling Due Within One Year
 5 
(1,466)
(1,394)

Net current assets
  
 
 
2,159
 
 
12,163

Total assets less current liabilities
  
2,159
12,163

  

Net assets
  
2,159
12,163


Represented by:
  

Loans and other debts due to members within one year
  

Other amounts
 6 
2,159
12,163

  
2,159
12,163

  

  
2,159
12,163


Total members' interests
  

Loans and other debts due to members
 6 
2,159
12,163

  
2,159
12,163


Page 2

 
NORFOLK HAEMATOLOGY PARTNERSHIP LLP
REGISTERED NUMBER: OC428034
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2024

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small LLPs regime.

The entity was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, with respect to accounting records and the preparation of financial statements.

The financial statements have been delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.

The entity has opted not to file the profit and loss account in accordance with the provisions applicable to entities subject to the small LLPs regime.

The financial statements were approved and authorised for issue by the members and were signed on their behalf on 25 October 2024.






M J Lawes
Designated member

The notes on pages 4 to 6 form part of these financial statements.

Norfolk Haematology Partnership LLP has no equity and, in accordance with the provisions contained within the Statement of Recommended Practice "Accounting by Limited Liability Partnerships", has not presented a Statement of changes in equity.

Page 3

 
NORFOLK HAEMATOLOGY PARTNERSHIP LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

1.


General information

The LLP is a United Kingdom Limited Liability Partnership. It is both incorporated and domiciled in England and Wales. The address of its registered office is 7 The Close, Norwich, Norfolk, NR1 4DJ.
The LLP's principal activity is that of providing private haematology services to patients across Norwich and Norfolk. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Turnover represents fees charged to patients or third-party payers for diagnostic services, treatments, screening and reporting and is recognised at the point the service is provided.

 
2.3

Division and distribution of profits

A division of profits is the mechanism by which the profits of an LLP become a debt due to members. A division may be automatic or discretionary, may relate to some or all of the profits for a financial period and may take place during or after the end of a financial period.

An automatic division of profits is one where the LLP does not have an unconditional right to avoid making a division of an amount of profits based on the members' agreement in force at the time, whereas a discretionary division of profits requires a decision to be made by the LLP, which it has the unconditional right to avoid making.

The LLP divides profits automatically. Automatic divisions of profits are recognised as 'Members' remuneration charged as an expense in .

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 4

 
NORFOLK HAEMATOLOGY PARTNERSHIP LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees




The entity has no employees.


4.


Information in relation to members

2024
2023
Number
Number



Average number of members during the year
3
3


5.


Creditors: Amounts falling due within one year

2024
2023
£
£

Accruals and deferred income
1,466
1,394

1,466
1,394


Page 5

 
NORFOLK HAEMATOLOGY PARTNERSHIP LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024

6.


Loans and other debts due to members


2024
2023
£
£



Other amounts due to members
2,159
12,163

2,159
12,163

Loans and other debts due to members may be further analysed as follows:

2024
2023
£
£



Falling due after more than one year
2,159
12,163

2,159
12,163

Loans and other debts due to members rank equally with debts due to ordinary creditors in the event of a winding up.

 
Page 6